BIOASTER, today announced a collaboration with QIAGEN for the development of a molecular diagnostic assay running on the QIAGEN’s QIAstat-Dx platform.
The primary objective of the collaboration is to expand and speed up the development of the panel of clinical applications with QIAGEN’s syndromic testing solution in the field of infectious diseases.
Upload the complete Press Release: HERE